Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (181-190 of 350) with videos related to

Pageof 35
Sort By:
The Oncologist|May 8, 2026
Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysisChan Shen, Madison Conces, Kristen Ciombor, et al.
The Oncologist|April 19, 2026
Trends in Primary Surgery and Overall Survival in Non-Metastatic Anal Cancer: A Population-Based AnalysisChan Shen, Madison Conces, Kristen Ciombor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysisPolina Khrizman, Joyce C Niland, Anna ter Veer, et al.
Neuroendocrinology|September 10, 2020
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom IndexSara Shaunfield, Kimberly A Webster, Karen Kaiser, et al.
Journal of Hepatology|September 25, 2012
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progressionKhairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Pancreas|May 3, 2021
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes DatabaseHilary Chan, Li Zhang, Michael A Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatinLeonard L Gunderson, Kathryn A Winter, Jaffer A Ajani, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trialLeonard L Gunderson, Jennifer Moughan, Jaffer A Ajani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2025
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research PhysiciansDavid E Gerber, Nikhil I Khushalani, Ang Gao, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 4, 2016
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular CarcinomaRyan Hickey, Samdeep Mouli, Laura Kulik, et al.
Pageof 35

Showing results (181-190 of 350) with videos related to

Sort By:
Pageof 35
The Oncologist|May 8, 2026
Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysisChan Shen, Madison Conces, Kristen Ciombor, et al.
The Oncologist|April 19, 2026
Trends in Primary Surgery and Overall Survival in Non-Metastatic Anal Cancer: A Population-Based AnalysisChan Shen, Madison Conces, Kristen Ciombor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysisPolina Khrizman, Joyce C Niland, Anna ter Veer, et al.
Neuroendocrinology|September 10, 2020
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom IndexSara Shaunfield, Kimberly A Webster, Karen Kaiser, et al.
Journal of Hepatology|September 25, 2012
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progressionKhairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Pancreas|May 3, 2021
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes DatabaseHilary Chan, Li Zhang, Michael A Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatinLeonard L Gunderson, Kathryn A Winter, Jaffer A Ajani, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trialLeonard L Gunderson, Jennifer Moughan, Jaffer A Ajani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2025
Protected Time, Resources, and Expectations for Academic Oncology Clinical Research PhysiciansDavid E Gerber, Nikhil I Khushalani, Ang Gao, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 4, 2016
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular CarcinomaRyan Hickey, Samdeep Mouli, Laura Kulik, et al.
Pageof 35